Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2017

Feb 13, 2017

30237_dirs_2017-02-13_93994baf-635a-4177-97cf-3b4c59665c64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-02-09

Reporting Person: KING DAVID P (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-09 Common Stock M 7543 Acquired 139687.6154 Direct
2017-02-09 Common Stock F 2496 $133.83 Disposed 137191.6154 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-09 Restricted Stock Unit $ M 7543 Disposed Common Stock (7543) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 16942 Indirect
Common Stock 31601 Indirect
Common Stock 10314 Indirect

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 40.5601 shares acquired on December 31, 2016 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.